Lineage Cell Therapeutics, Inc.
LCTXLineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 6, 2026
TomorrowMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
LCTX Earnings Report
EPS Est: $-0.03 | FQ end 2026-06 | Call: 2026-08-06 15:00:00
How LCTX's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AST-OPC1 | Phase 2 | Cervical Spinal Cord Injury | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Lineage Cell Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Lineage Cell Therapeutics, Inc.'s (LCTX) pipeline across Phase 2. Its lead program is AST-OPC1 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Lineage Cell Therapeutics, Inc.'s next FDA catalyst?→
Lineage Cell Therapeutics, Inc.'s (LCTX) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track LCTX biotech catalysts?→
Add LCTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Lineage Cell Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.